Drug screening against F13 protein, the target of tecovirimat, as potential therapies for monkeypox virus

J Infect. 2023 Feb;86(2):154-225. doi: 10.1016/j.jinf.2022.11.018. Epub 2022 Nov 25.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Benzamides*
  • Drug Evaluation, Preclinical
  • Humans
  • Monkeypox virus*

Substances

  • Benzamides